Ascendis Pharma Bone Diseases A/S is a biotechnology company based in Hellerup, Denmark, focused on developing innovative therapies for bone-related conditions. The organization specializes in the research and development of novel treatments that leverage its proprietary TransCon technology platform, which aims to enhance the efficacy and safety of therapeutic proteins. Ascendis Pharma is committed to addressing unmet medical needs in the field of bone diseases, contributing to advancements in patient care and treatment outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#4 in Hellerup

#273 in Denmark

#56,092 in the World

Hellerup, Denmark

Ascendis Pharma Bone Diseases A/s

Forward Citations = 28

12 inventors:

Kennett Sprogøe (10 out of 31 patents)

Felix Cleemann (8 out of 25 patents)

Thomas Wegge (8 out of 38 patents)

4. Guillaume Maitro (8 out of 13 patents)

5. Joachim Zettler (8 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ascendis Pharma Bone Diseases A/s. Retrieved from https://idiyas.com/company/ascendis-pharma-bone-diseases-a-s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

6 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]